Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity. (Q39543380)
Jump to navigation
Jump to search
scientific article published on 16 May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity. |
scientific article published on 16 May 2011 |
Statements
Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity (English)
S M Rudman
D H Josephs
H Cambrook
P Karagiannis
A E Gilbert
T Dodev
J Hunt
A Koers
A Montes
S Canevari
C F Nicodemus
S B Kaye
F O Nestle
J F Spicer
S N Karagiannis
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference